1. Home
  2. BLIN vs CTXR Comparison

BLIN vs CTXR Comparison

Compare BLIN & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLIN
  • CTXR
  • Stock Information
  • Founded
  • BLIN 2000
  • CTXR 2007
  • Country
  • BLIN United States
  • CTXR United States
  • Employees
  • BLIN N/A
  • CTXR N/A
  • Industry
  • BLIN EDP Services
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLIN Technology
  • CTXR Health Care
  • Exchange
  • BLIN Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • BLIN 16.5M
  • CTXR 14.6M
  • IPO Year
  • BLIN 2007
  • CTXR N/A
  • Fundamental
  • Price
  • BLIN $1.39
  • CTXR $1.58
  • Analyst Decision
  • BLIN Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • BLIN 1
  • CTXR 3
  • Target Price
  • BLIN $4.62
  • CTXR $53.00
  • AVG Volume (30 Days)
  • BLIN 27.0K
  • CTXR 6.8M
  • Earning Date
  • BLIN 08-13-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • BLIN N/A
  • CTXR N/A
  • EPS Growth
  • BLIN N/A
  • CTXR N/A
  • EPS
  • BLIN N/A
  • CTXR N/A
  • Revenue
  • BLIN $15,465,000.00
  • CTXR N/A
  • Revenue This Year
  • BLIN $4.08
  • CTXR N/A
  • Revenue Next Year
  • BLIN $12.95
  • CTXR N/A
  • P/E Ratio
  • BLIN N/A
  • CTXR N/A
  • Revenue Growth
  • BLIN 1.30
  • CTXR N/A
  • 52 Week Low
  • BLIN $0.76
  • CTXR $0.65
  • 52 Week High
  • BLIN $2.80
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • BLIN 34.15
  • CTXR 68.44
  • Support Level
  • BLIN $1.41
  • CTXR $0.76
  • Resistance Level
  • BLIN $1.56
  • CTXR $1.45
  • Average True Range (ATR)
  • BLIN 0.07
  • CTXR 0.31
  • MACD
  • BLIN -0.01
  • CTXR 0.06
  • Stochastic Oscillator
  • BLIN 5.42
  • CTXR 47.63

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: